Sickle cell disease: open trials in Lebanon

• NCT06198712

  A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease

  Trial Treatment · Phase 2 · Forma Therapeutics, Inc.

  American University of Beirut Medical Center, Beirut · Hospital Nini, Tripoli

  Registry updated 2026-09-18

• NCT06609226

  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  American University of Beirut Medical Centre, Hamra · Chronic Care Center, Hazmiyeh · Hospital Nini, Tripoli

  Registry updated 2026-09-18

• NCT06612268

  A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  American University of Beirut Medical Centre, Hamra · Hospital Nini, Tripoli

  Registry updated 2026-09-17

• NCT04657822

  Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Beirut · Tripoli

  Registry updated 2026-06-08

All Sickle cell disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error